Industrial biotechnology

Our research in the field of industrial biotechnology focuses on the demand for sustainable supplies of materials, fuels and food by replacing traditional chemical processes with sustainable and environmentally-friendly biological methods.

Our facilities

Deakin's world-class industrial biotechnology facility is fully equipped for:

  • Microbial bioprocessing 
  • Chemical and biochemical analyses 
  • Process development

Research priorities

Micro-organisms are used as cell factories for producing industrially useful materials. At CCB, we want to discover sustainable supplies of materials, fuels and food through biological means. 

We’re particularly interested in omega-3 fatty acids, inflammatory signalling molecules, carotenoids, flavonoids, hydrolytic enzymes, and value-added ingredients from under-utilised biomass and micro-organisms.

Our research focuses on:

  • Bioprospecting for new marine micro-organisms that produce omega-3 fatty acids, lipids and enzymes
  • Enzymatic synthesis, microencapsulation and biological evaluation of omega-3 oils and their derivatives
  • Immobilizing enzymes such as lipases, rhamnosidases and proteases on nanomaterials for food processing applications
  • Bioprocess development for the expression and production of therapeutics (plant proteins) and marine peptides
  • Enzymatic processing of agriculture waste biomass to produce fuels and chemicals
  • Using lipases as catalysts for chemical synthesis.

Through our research we’ve also established strong connections with highly-recognised national and international organisations, including CSIRO (Parkville), BIO21 (Monash), Indian-oil (India), TERI (India), Qingdao University (China) and Plant & Food (New Zealand).

Featured staff

Alfred Deakin Professor Colin Barrow is Director of the Centre for Chemistry and Biotechnology. His research interests include natural products chemistry, biological chemistry, food biotechnology and omega-3 oil technology.

Professor Barrow has contributed to 180 publications (averaging 27 citations per paper) and has received over $6M in funding so far. He has also been awarded an ARC LIEF grant, an ARC Linkage grant (lead Chief Investigator) and five patents.

Contact us

Group Coordinator
Professor Colin Barrow
+61 3 5227 1318
Email Professor Barrow